Sr Director, US Medical Early Assets - Market Access
Core
Strategic lead for shaping US market access and value strategy for early pipeline assets (late discovery through Phase 2) to ensure payer, health-system, and policy needs are integrated into asset development and investment decisions.
Role type
Senior Director, US Market Access Strategy
Builds
US value strategies, evidence generation plans, pricing hypotheses, and investment recommendations for early-stage biopharma assets.
Domain
Biopharmaceuticals / US Healthcare Market Access
Deliverable
production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work
Required skills
US payer strategy, health economics outcomes research (HEOR), real-world evidence (RWE) planning, economic modeling, pricing and contracting strategy, policy landscape analysis, cross-functional leadership, stakeholder influence, strategic forecasting
Preferred skills
Advanced degree in health economics/public health/pharmacy, experience with first-in-class assets, global asset strategy influence, value-based access approaches, therapeutic area expertise
Technologies
AMCP dossiers, rNPV/scenario analysis tools, utilization management systems
Responsibilities
Define US Target Product Profile elements and differentiation claims; influence clinical and RWE study design for payer coverage; develop early value propositions and economic models; establish pricing and contracting hypotheses; analyze policy and channel dynamics; synthesize payer insights to de-risk access; support governance decisions with evidence-based recommendations.
Seniority
Senior Director, strategic leadership with cross-functional influence
